ARTICLES
Preaching to the choir: new voices in the end of life discussion
JA Jacobson
JCO Feb 1 1997: 413–415. [PDF]
Donor lymphocyte infusions: the door is open
RJ Soiffer
JCO Feb 1 1997: 416–417. [PDF]
	Euthanasia and physician-assisted suicide: a comparative survey of physicians, terminally ill cancer patients, and the general population
	ME Suarez-Almazor, M Belzile, and E Bruera
	JCO Feb 1 1997: 418–427. [Abstract] [PDF]
	Physician desire for euthanasia and assisted suicide: would physicians practice what they preach?
	OM Howard, DL Fairclough, ER Daniels, and EJ Emanuel
	JCO Feb 1 1997: 428–432. [Abstract] [PDF]
	Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
	RH Collins, Jr, O Shpilberg, WR Drobyski, DL Porter, S Giralt, R Champlin, SA Goodman, SN Wolff, W Hu, C Verfaillie, A List, W Dalton, N Ognoskie, A Chetrit, JH Antin, and J Nemunaitis
	JCO Feb 1 1997: 433–444. [Abstract] [PDF]
	High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma
	PJ Bierman, JM Vose, JR Anderson, MR Bishop, A Kessinger, and JO Armitage
	JCO Feb 1 1997: 445–450. [Abstract] [PDF]
	Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit
	IG McQuaker, AE Hunter, S Pacey, AP Haynes, A Iqbal, and NH Russell
	JCO Feb 1 1997: 451–457. [Abstract] [PDF]
	Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report
	JM Sorensen, DA Vena, A Fallavollita, HG Chun, and BD Cheson
	JCO Feb 1 1997: 458–465. [Abstract] [PDF]
	Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461
	JC Byrd, RB Weiss, DC Arthur, D Lawrence, MR Baer, F Davey, ES Trikha, AJ Carroll, R Tantravahi, M Qumsiyeh, SR Patil, JO Moore, RJ Mayer, CA Schiffer, and CD Bloomfield
	JCO Feb 1 1997: 466–475. [Abstract] [PDF]
	Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group
	AW Dekker, MB van't Veer, W Sizoo, HL Haak, J van der Lelie, G Ossenkoppele, PC Huijgens, HC Schouten, P Sonneveld, R Willemze, LF Verdonck, WL van Putten, and B Lowenberg
	JCO Feb 1 1997: 476–482. [Abstract] [PDF]
	Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine
	E Estey, PF Thall, S Pierce, H Kantarjian, and M Keating
	JCO Feb 1 1997: 483–490. [Abstract] [PDF]
	Intensified and high-dose chemotherapy with granulocyte colony- stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma
	U Vitolo, S Cortellazzo, AM Liberati, R Freilone, M Falda, M Bertini, B Botto, S Cinieri, A Levis, F Locatelli, E Lovisone, F Marmont, M Pizzuti, A Rossi, P Viero, T Barbui, F Grignani, and L Resegotti
	JCO Feb 1 1997: 491–498. [Abstract] [PDF]
	Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients
	K Warzocha, G Salles, J Bienvenu, Y Bastion, C Dumontet, N Renard, EM Neidhardt- Berard, and B Coiffier
	JCO Feb 1 1997: 499–508. [Abstract] [PDF]
	Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
	I Majolino, R Pearce, G Taghipour, and AH Goldstone
	JCO Feb 1 1997: 509–517. [Abstract] [PDF]
	Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients
	E Salloum, DS Brandt, VJ Caride, E Cornelius, D Zelterman, W Schubert, T Mannino, and DL Cooper
	JCO Feb 1 1997: 518–527. [Abstract] [PDF]
	Outcome of patients with Hodgkin's disease failing after primary MOPP- ABVD
	V Bonfante, A Santoro, S Viviani, L Devizzi, M Balzarotti, F Soncini, M Zanini, P Valagussa, and G Bonadonna
	JCO Feb 1 1997: 528–534. [Abstract] [PDF]
	Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma
	MJ Watts, AM Sullivan, E Jamieson, R Pearce, A Fielding, S Devereux, AH Goldstone, and DC Linch
	JCO Feb 1 1997: 535–546. [Abstract] [PDF]
	Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: a cooperative Children's Cancer Group and National Institutes of Health study
	LK Zeltzer, E Chen, R Weiss, MD Guo, LL Robison, AT Meadows, JL Mills, HS Nicholson, and J Byrne
	JCO Feb 1 1997: 547–556. [Abstract] [PDF]
	Unrelated donor bone marrow transplantation for children with acute leukemia
	SM Davies, JE Wagner, XO Shu, BR Blazar, E Katsanis, PJ Orchard, JH Kersey, KE Dusenbery, DJ Weisdorf, PB McGlave, and NK Ramsay
	JCO Feb 1 1997: 557–565. [Abstract] [PDF]
	Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood
	F Locatelli, C Niemeyer, E Angelucci, C Bender-Gotze, S Burdach, W Ebell, W Friedrich, H Hasle, J Hermann, N Jacobsen, T Klingebiel, B Kremens, G Mann, A Pession, C Peters, HJ Schmid, J Stary, M Suttorp, C Uderzo, ET van't Veer- Korthof, J Vossen, M Zecca, and M Zimmermann
	JCO Feb 1 1997: 566–573. [Abstract] [PDF]
	Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991
	RB Raney, L Asmar, WA Newton, Jr, C Bagwell, JC Breneman, W Crist, EA Gehan, B Webber, M Wharam, ES Wiener, JR Anderson, and HM Maurer
	JCO Feb 1 1997: 574–582. [Abstract] [PDF]
	Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor
	DC West, HE Grier, MM Swallow, GD Demetri, L Granowetter, and J Sklar
	JCO Feb 1 1997: 583–588. [Abstract] [PDF]
	Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma
	RS Witte, P Elson, B Bono, R Knop, RR Richardson, R Dreicer, and Sr Loehrer PJ
	JCO Feb 1 1997: 589–593. [Abstract] [PDF]
	International Germ Cell Consensus Classification: a prognostic factor- based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group
	JCO Feb 1 1997: 594–603. [Abstract] [PDF]
	Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma
	JA Lacava, BA Leone, M Machiavelli, AO Romero, JE Perez, YL Elem, R Ferreyra, G Focaccia, G Suttora, MA Salvadori, MA Cuevas, LR Acuna, JR Acuna, M Langhi, S Amato, J Castaldi, A Arroyo, and CT Vallejo
	JCO Feb 1 1997: 604–609. [Abstract] [PDF]
	Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer
	P Viladiu, FX Bosch, X Castellsague, N Munoz, JM Escriba, E Hamsikova, V Hofmannova, E Guerrero, A Izquierdo, C Navarro, P Moreo, I Izarzugaza, N Ascunce, M Gili, MT Munoz, L Tafur, KV Shah, and V Vonka
	JCO Feb 1 1997: 610–619. [Abstract] [PDF]
	Surveillance policy for stage I ovarian germ cell tumors
	GG Dark, M Bower, ES Newlands, F Paradinas, and GJ Rustin
	JCO Feb 1 1997: 620–624. [Abstract] [PDF]
	Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix
	CF Verschraegen, T Levy, AP Kudelka, E Llerena, K Ende, RS Freedman, CL Edwards, M Hord, M Steger, AL Kaplan, D Kieback, A Fishman, and JJ Kavanagh
	JCO Feb 1 1997: 625–631. [Abstract] [PDF]
	Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective
	LM Elit, A Gafni, and MN Levine
	JCO Feb 1 1997: 632–639. [Abstract] [PDF]
	Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancer
	W McGuire, AI Neugut, S Arikian, J Doyle, and CM Dezii
	JCO Feb 1 1997: 640–645. [Abstract] [PDF]
	Association of local recurrence with subsequent survival in extremity soft tissue sarcoma
	JJ Lewis, D Leung, M Heslin, JM Woodruff, and MF Brennan
	JCO Feb 1 1997: 646–652. [Abstract] [PDF]
	Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS- related Kaposi's sarcoma after failure of standard chemotherapy
	DW Northfelt, BJ Dezube, JA Thommes, R Levine, JH Von Roenn, GM Dosik, A Rios, SE Krown, C DuMond, and RD Mamelok
	JCO Feb 1 1997: 653–659. [Abstract] [PDF]
	Prospective randomized placebo-controlled study of granulocyte- macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma
	P Moreau, D Fiere, WR Bezwoda, T Facon, M Attal, JP Laporte, P Colombat, HL Haak, M Monconduit, H Lockhorst, D Girault, and JL Harousseau
	JCO Feb 1 1997: 660–666. [Abstract] [PDF]
	Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue
	S Giralt, D Weber, M Colome, M Dimopoulos, R Mehra, K Van Besien, J Gajewski, B Andersson, I Khouri, D Przepiorka, B von Wolff, K Delasalle, M Korbling, D Seong, R Alexanian, and R Champlin
	JCO Feb 1 1997: 667–673. [Abstract] [PDF]
	Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients
	CL Shapiro, L Ayash, IJ Webb, R Gelman, J Keating, L Williams, G Demetri, P Clark, A Elias, D Duggan, D Hayes, D Hurd, and IC Henderson
	JCO Feb 1 1997: 674–683. [Abstract] [PDF]
	Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony- stimulating factor
	T Demirer, CD Buckner, B Storer, K Lilleby, S Rowley, R Clift, FR Appelbaum, R Storb, and WI Bensinger
	JCO Feb 1 1997: 684–690. [Abstract] [PDF]
	Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer
	BG Haffty, B Ward, P Pathare, R Salem, C McKhann, M Beinfield, D Fischer, and M Reiss
	JCO Feb 1 1997: 691–700. [Abstract] [PDF]
	Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus
	G Ganem, B Dubray, Y Raoul, P Colin, E Bardet, JY Douillard, MJ Goudier, C Hennequin, S Walter, P Michel-Langlet, P Martin, D Maron, F Morvan, P Andolenko, and JM Extra
	JCO Feb 1 1997: 701–711. [Abstract] [PDF]
	Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer
	NC Choi, RW Carey, W Daly, D Mathisen, J Wain, C Wright, T Lynch, M Grossbard, and H Grillo
	JCO Feb 1 1997: 712–722. [Abstract] [PDF]
	Immunotoxin therapy of small-cell lung cancer: a phase I study of N901- blocked ricin
	TJ Lynch, Jr, JM Lambert, F Coral, J Shefner, P Wen, WA Blattler, AR Collinson, PD Ariniello, G Braman, S Cook, D Esseltine, A Elias, A Skarin, and J Ritz
	JCO Feb 1 1997: 723–734. [Abstract] [PDF]
	Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer
	MS Georgiadis, BS Schuler, JE Brown, LV Kieffer, SM Steinberg, WH Wilson, CH Takimoto, MJ Kelley, and BE Johnson
	JCO Feb 1 1997: 735–743. [Abstract] [PDF]
	Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer
	RP Abratt, WR Bezwoda, L Goedhals, and DJ Hacking
	JCO Feb 1 1997: 744–749. [Abstract] [PDF]
	Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer
	MJ Millward, J Zalcberg, JF Bishop, LK Webster, A Zimet, D Rischin, GC Toner, J Laird, W Cosolo, M Urch, R Bruno, C Loret, R James, and C Blanc
	JCO Feb 1 1997: 750–758. [Abstract] [PDF]
	Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease
	EA Copelan, SK Ceselski, SA Ezzone, LC Lasky, SL Penza, TP Bechtel, JL Klein, DM Hehmeyer, MD Scholl, DD Marshall, PJ Elder, GL Risley, and BR Avalos
	JCO Feb 1 1997: 759–765. [Abstract] [PDF]
	Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer
	N Soni, NJ Meropol, L Pendyala, D Noel, LP Schacter, KE Gunton, and PJ Creaven
	JCO Feb 1 1997: 766–772. [Abstract] [PDF]
	Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors
	CA Johnson, D Kilpatrick, R von Roemeling, C Langer, MA Graham, D Greenslade, G Kennedy, E Keenan, and PJ O'Dwyer
	JCO Feb 1 1997: 773–780. [Abstract] [PDF]
	Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor
	J Berlin, KD Tutsch, P Hutson, J Cleary, RP Rago, RZ Arzoomanian, D Alberti, C Feierabend, and G Wilding
	JCO Feb 1 1997: 781–789. [Abstract] [PDF]
	Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
	VA Miller, FM Benedetti, JR Rigas, AL Verret, DG Pfister, D Straus, MG Kris, M Crisp, R Heyman, GR Loewen, JA Truglia, and RP Warrell, Jr
	JCO Feb 1 1997: 790–795. [Abstract] [PDF]
	Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2
	AE Chang, A Aruga, MJ Cameron, VK Sondak, DP Normolle, BA Fox, and S Shu
	JCO Feb 1 1997: 796–807. [Abstract] [PDF]
	Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study
	A de Gramont, JF Bosset, C Milan, P Rougier, O Bouche, PL Etienne, F Morvan, C Louvet, T Guillot, E Francois, and L Bedenne
	JCO Feb 1 1997: 808–815. [Abstract] [PDF]
	Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer
	S Nakamori, H Furukawa, M Hiratsuka, T Iwanaga, S Imaoka, O Ishikawa, T Kabuto, Y Sasaki, M Kameyama, S Ishiguro, and T Irimura
	JCO Feb 1 1997: 816–825. [Abstract] [PDF]
	Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma
	N Tanigawa, H Amaya, M Matsumura, and T Shimomatsuya
	JCO Feb 1 1997: 826–832. [Abstract] [PDF]
	High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency
	GA Smith, LE Damon, HS Rugo, CA Ries, and CA Linker
	JCO Feb 1 1997: 833–839. [Abstract] [PDF]
	Clinical potential of new antiestrogens
	WJ Gradishar and VC Jordan
	JCO Feb 1 1997: 840–852. [Abstract] [PDF]
Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology
JCO Feb 1 1997: 853–859. [PDF]
Sweet's syndrome
E Vance, S Granter, and A Skarin
JCO Feb 1 1997: 860–861. [PDF]
Breast cancer: relevance of estrogen receptor determination at relapse
V Spataro and A Goldhirsch
JCO Feb 1 1997: 862a. [PDF]
Granulocyte-macrophage colony-stimulating factor with induction treatment of acute myelogenous leukemia
DR Adkins, RA Brown, and JF DiPersio
JCO Feb 1 1997: 862b–863. [PDF]
Guidelines for the use of carcinoembryonic antigen in colorectal cancer
CD Atkins
JCO Feb 1 1997: 863–864. [PDF]
Systematic surgical staging: stage I ovarian cancer
MS Piver
JCO Feb 1 1997: 864–865. [PDF]
Delayed complication of Port-A-Cath: perforation of the superior vena cava
N Kulvatunyou, J Rucinski, and M Schein
JCO Feb 1 1997: 865. [PDF]

SPECIAL DEPARTMENTS
Errata
	Progress Report of Combined Chemoradiotherapy Versus Radiotherapy Alone in Patients With Esophageal Cancer: An Intergroup Study
	M. Al-Sarraf, K. Martz, A. Herskovic, L. Leichman, J.S. Brindle, V.K. Vaitkevicius, J. Cooper, R. Byhardt, L. Davis, and B. Emami
	JCO Feb 1 1997: 866. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.